Previous Close | 31.02 |
1-Year Change | -44.12% |
6-Months Change | -31.01% |
3-Months Change | -29.76% |
Moving Avg (50d) | 37.444 |
Moving Avg (200d) | 42.687 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.49B |
Beta (3-Years) | 0.58 |
Revenue Growth (ttm) | 24.02% |
Net Profit Margin (ttm) | 22.5% |
Return On Assets (ttm) | 8.76% |
EPS (ttm) | 2.55 |
PE Ratio (ttm) | 12.16 |
Dividend Yield | % |
Asset Description: | Amphastar Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-01-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
31.64 | 32.571 | 33.191 | 34.122 | 35.673 | 37.224 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |